Systems pharmacogenomics identifies novel targets and clinically actionable therapeutics for medulloblastoma.
Genovesi LA, Millar A, Tolson E, Singleton M, Hassall E, Kojic M, Brighi C, Girard E, Andradas C, Kuchibhotla M, Bhuva DD, Endersby R, Gottardo NG, Bernard A, Adolphe C, Olson JM, Taylor MD, Davis MJ, Wainwright BJ.
Genovesi LA, et al.
Genome Med. 2021 Jun 21;13(1):103. doi: 10.1186/s13073-021-00920-z.
Genome Med. 2021.
PMID: 34154646
Free PMC article.